Medicare Enrolled
Dr. Suzette Chin, MD
Critical Care Medicine · Cartersville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chin
Dr. Suzette Chin is a critical care medicine specialist in Cartersville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chin performed 2,377 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chin received a total of $12,399 from 52 pharmaceutical and/or device companies across 666 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in GA
$12,399 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,377
Medicare services
Top 12% in GA for critical care medicine
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $90 | $280 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
434 | $92 | $245 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
420 | $62 | $206 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
242 | $24 | $117 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
177 | $32 | $96 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
135 | $30 | $94 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
124 | $60 | $169 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
89 | $127 | $411 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
48 | $162 | $589 |
| New patient office visit, complex (60-74 min) | 47 | $163 | $494 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
46 | $24 | $73 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
40 | $28 | $93 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
32 | $52 | $156 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
28 | $65 | $519 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
19 | $6 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $123 | $392 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $109 | $378 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $29 | $69 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,399
Total received (2018-2024)
Avg $1,771/year across 7 years
Top 14% in GA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
666
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,322
2023
$2,113
2022
$1,753
2021
$1,591
2020
$1,705
2019
$1,924
2018
$1,990
Payments by company (2024)
Boehringer Ingelheim Pharmaceuticals, Inc.
$211
Mallinckrodt Hospital Products Inc.
$185
GlaxoSmithKline, LLC.
$179
AstraZeneca Pharmaceuticals LP
$171
Regeneron Healthcare Solutions, Inc.
$126
Merck Sharp & Dohme LLC
$57
Mylan Specialty L.P.
$55
United Therapeutics Corporation
$55
Actelion Pharmaceuticals US, Inc.
$50
Resmed Corp
$47
Amgen Inc.
$40
ANI Pharmaceuticals, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$31
Grifols USA, LLC
$23
Philips North America LLC
$22
GENZYME CORPORATION
$20
Fisher & Paykel Healthcare Inc
$18
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,812
AstraZeneca Pharmaceuticals LP
$1,472
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,406
Mallinckrodt Hospital Products Inc.
$925
Grifols USA, LLC
$777
Actelion Pharmaceuticals US, Inc.
$726
Mylan Specialty L.P.
$575
Genentech USA, Inc.
$520
United Therapeutics Corporation
$503
Sunovion Pharmaceuticals Inc.
$377
Intuitive Surgical, Inc.
$293
Regeneron Healthcare Solutions, Inc.
$241
Teva Pharmaceuticals USA, Inc.
$197
Takeda Pharmaceuticals U.S.A., Inc.
$176
Gilead Sciences, Inc.
$173
Inari Medical, Inc.
$166
Mallinckrodt Enterprises LLC
$158
Insmed, Inc.
$157
Amgen Inc.
$141
ANI Pharmaceuticals, Inc.
$128
Merck Sharp & Dohme LLC
$108
GENZYME CORPORATION
$105
Mallinckrodt LLC
$99
Eisai Inc.
$80
PORTOLA PHARMACEUTICALS, INC.
$79
Philips Electronics North America Corporation
$70
Allergan, Inc.
$65
Resmed Corp
$62
Jazz Pharmaceuticals Inc.
$61
Fisher & Paykel Healthcare Inc
$57
Merck Sharp & Dohme Corporation
$54
PFIZER INC.
$53
Harmony Biosciences LLC
$48
Janssen Pharmaceuticals, Inc
$45
Vapotherm Inc
$43
Bayer HealthCare Pharmaceuticals Inc.
$41
AbbVie Inc.
$41
Shire North American Group Inc
$40
Medtronic, Inc.
$38
Advanced Respiratory, Inc
$37
La Jolla Pharmaceutical Company
$32
ABBVIE INC.
$32
Veran Medical Technologies, Inc.
$26
Baxter Healthcare
$23
Allergan Inc.
$22
Philips North America LLC
$22
Olympus America Inc.
$18
Electromed, Inc.
$17
Covis Pharma GmBH
$17
Circassia Pharmaceuticals Inc
$15
Foundation Medicine, Inc.
$14
Novartis Pharmaceuticals Corporation
$14
Top 3 companies account for 37.8% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (8874) inCourage · (AK6) Vest Therapy · 120V · 60Hz · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ALVESCO · AMITIZA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · COMBIVENT RESPIMAT · DUPIXENT · Da Vinci Surgical System · Dayvigo · Dymista · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · FOUNDATIONONE · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · ILLUMISITE · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PREVNAR - 13 · PREVNAR 20 · PT100US/myAIRVO 2 · PURIFIED CORTROPHIN GEL · Precision Flow · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · S · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · UTIBRON NEOHALER · Utibron · VAPOTHERM · Veklury · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
5
County median income
$79,431
Nearest hospital to ZIP centroid (approximate)
PIEDMONT CARTERSVILLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chin is a clinical cardiology specialist, with above-average Medicare volume (top 12% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chin performed 457 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chin receive payments from pharmaceutical companies?
Yes. Dr. Chin received a total of $12,399 from 52 companies across 666 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chin's costs compare to other critical care medicines in Cartersville?
Dr. Chin's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Cartersville
Browse critical care medicines in Cartersville ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in GA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in GA
Which GA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology